
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein Inc. demonstrates a positive financial outlook, highlighted by significant growth across its business segments, particularly in the Global Distribution and Value-Added Services segment, which includes essential products and services for dental and medical practitioners. The company's medical products revenue experienced a 4.7% increase, while dental business revenue rose by 5.5%, indicating strong demand in both markets. Additionally, the Global Technology segment reported revenue of $173 million, growing 9.7%, underscoring the company's strategic focus on technology solutions and signaling ongoing expansion potential.
Bears say
Henry Schein Inc reported a gross margin of 30.7% for the quarter, falling short of the expected 31.6%, indicating challenges in maintaining profitability within its Global Distribution and Value-Added Services segment. Additionally, the company's outlook suggests that remeasurement gains will decrease in 2026 compared to 2025, reflecting underlying financial difficulties and an unfavorable mix affecting both distribution and specialty products. Despite some positive contributions from mergers and acquisitions and foreign currency fluctuations, the overall performance points to potential weaknesses that could adversely impact Henry Schein's financial stability.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares